About
Who We Are
Leadership Team
Board of Directors
Clinical and Scientific Advisors
Contact
Science
Immune Continuum
Immunoglobulin E (IgE) in Allergic Conditions
CCR4 in Inflammation
Pipeline
Snapshot
RPT904
Investors
Corporate Profile
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Email Alerts
Investor Contact
Investor FAQs
Careers
Culture
Benefits
Open Positions
BRINGING NOVEL INVESTIGATIONAL TREATMENTS FOR ECZEMA, ASTHMA and cancer ONE STEP CLOSER TO APPROVAL
RAPT Therapeutics Announces Private Placement Financing of $50 Million
May 25, 2022
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
